Evidence map›Paper›PMID 41250183›Full record

ArticleOrphanet journal of rare diseases2025

Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Sebile Kilavuz, Kerri-Lee Wallom, Ana Catarina Gomes Almeida Augusto Caçote, Aimée Donald, Simona D'Amore, Kathy Page, Chong Yew Tan, Danielle Te Vruchte, Andrea Sturchio, Panagiota Tsitsi and 7 more

Abstract readPublished Erratum
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Sebile KilavuzDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.
Kerri-Lee WallomDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.
Ana Catarina Gomes Almeida Augusto CaçoteDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.
Aimée DonaldDivision of Neurosciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
Simona D'AmoreDepartment of Medicine, Cambridge Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust, University of Cambridge, London, UK.
Kathy PageDepartment of Medicine, University of Cambridge, Cambridge, UK.
Chong Yew TanDepartment of Medicine, University of Cambridge, Cambridge, UK.
Danielle Te VruchteDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.
Andrea SturchioDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Panagiota TsitsiDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Ellen HertzDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Mattias AndréassonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Ioanna MarkakiDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Timothy M CoxDepartment of Medicine, University of Cambridge, Cambridge, UK.
Frances M PlattDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. frances.platt@pharm.ox.ac.uk.ORCID http://orcid.org/0000-0001-7614-0403
MRC GAUCHERITE Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41250183
PMCPMC12624977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.